Inventor · disambiguated record
Jing Liu
Also filed as: LIU JING · LIU JING-YUAN
63 granted patents·46 pending applications·248 citations·filing 1991–2025
98Inventor score
Files withCULLGEN SHANGHAI INC17JANSSEN PHARMACEUTICA NV17ICAHN SCHOOL MED MOUNT SINAI9HEFEI INST PHYSICAL SCI CAS7TARAPEUTICS SCIENCE INC5
Top patents by PatentIndex Score
109 records- 0195US11155563B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2021·Granted Oct 26, 2021·3 cites·3 claims
- 0291US11981684B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 0391US11286264B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Mar 29, 2022·4 cites·21 claims
- 0490US9814709B2Bruton's tyrosine kinase inhibitorHEFEI INST PHYSICAL SCI CAS·Filed 2015·Granted Nov 14, 2017·16 cites·13 claims
- 0586US9079866B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 14, 2015·8 cites·7 claims
- 0685US12065442B2Tropomyosin receptor kinase (TRK) degradation compounds and methods of useCULLGEN SHANGHAI INC·Filed 2019·Granted Aug 20, 2024·2 cites·6 claims
- 0785US9073876B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 7, 2015·6 cites·7 claims
- 0884US11541051B2Compositions and methods for treating CDK4/6-mediated cancerICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Granted Jan 3, 2023·4 cites·15 claims
- 0984US7576092B2Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 18, 2009·6 cites·30 claims
- 1082US9265770B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·3 cites·11 claims
- 1181US11472799B2Serine threonine kinase (AKT) degradation / disruption compounds and methods of useICAHN SCHOOL MED MOUNT SINAI·Filed 2019·Granted Oct 18, 2022·4 cites·30 claims
- 1281US8952177B21,2,6-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 10, 2015·4 cites·9 claims
- 1380US12410171B2Tropomyosin receptor kinase (TRK) degradation compounds and methods of useCULLGEN SHANGHAI INC·Filed 2021·Granted Sep 9, 2025·1 cites·12 claims
- 1480US9067917B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·3 cites·9 claims
- 1579US9089569B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 28, 2015·3 cites·13 claims
- 1678US10517871B2Survivin-targeting anti-tumor agents and uses thereofUNIV INDIANA RES & TECH CORP·Filed 2016·Granted Dec 31, 2019·2 cites·17 claims
- 1778US9795606B2Pyrrolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Oct 24, 2017·2 cites·20 claims
- 1878US9273056B2Pyrrolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA·Filed 2012·Granted Mar 1, 2016·3 cites·41 claims
- 1978US2025388587A1Tropomyosin receptor kinase (trk) degradation compounds and methods of useCULLGEN SHANGHAI INC·Filed 2025·Application pending·0 cites
- 2077US9562047B2Pyrazolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2013·Granted Feb 7, 2017·3 cites·9 claims
- 2177US8288397B2Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1BRANSTETTER BRYAN JAMES·Filed 2008·Granted Oct 16, 2012·2 cites·20 claims
- 2277US5629156AMultiple capture probe sandwich assaysAMOCO CORP·Filed 1994·Granted May 13, 1997·88 cites·9 claims
- 2376US2024400570A1Tropomyosin receptor kinase (trk) degradation compounds and methods of useCULLGEN SHANGHAI INC·Filed 2024·Application pending·0 cites
- 2474US9290499B2Pyrazolopyrimidine compounds for the treatment of cancerWANG XIAODONG·Filed 2011·Granted Mar 22, 2016·3 cites·22 claims
- 2572US9926333B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 27, 2018·1 cites·8 claims
- 2672US9732093B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·1 cites·18 claims
- 2771US9884878B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 6, 2018·1 cites·6 claims
- 2871US9745328B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 29, 2017·1 cites·16 claims
- 2971US8637527B2Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1BRANSTETTER BRYAN JAMES·Filed 2012·Granted Jan 28, 2014·1 cites·19 claims
- 3070US9212381B2Methods and compositions for labeling polypeptidesHARVARD COLLEGE·Filed 2012·Granted Dec 15, 2015·1 cites·35 claims
- 3169US2024066136A1Modified proteins and protein degradersCULLGEN SHANGHAI INC·Filed 2023·Application pending·0 cites
- 3267US9045731B2Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytesLI RONALD·Filed 2008·Granted Jun 2, 2015·2 cites·3 claims
- 3366US2024003871A1Ipsc-derived astrocytes and methods of use thereofFUJIFILM CELLULAR DYNAMICS INC·Filed 2023·Application pending·0 cites
- 3465US9248144B2Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseasesBISHOPRIC NANETTE·Filed 2011·Granted Feb 2, 2016·2 cites·3 claims
- 3565US5521300AOligonucleotides complementary to mycobacterial nucleic acidsNORVAL B GALLOWAY·Filed 1991·Granted May 28, 1996·48 cites·6 claims
- 3664US2025325678A1Cyclic-amp response element binding protein (cbp) and/or adenoviral e1a binding protein of 300 kda (p300) degradation compounds and methods of useCULLGEN SHANGHAI INC·Filed 2025·Application pending·0 cites
- 3764US2024131173A1Protacs with transcription factor targeting moietiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2023·Application pending·0 cites
- 3864US2023167106A1Serine threonine kinase (akt) degradation / disruption compounds and methods of useICAHN SCHOOL MED MOUNT SINAI·Filed 2022·Application pending·0 cites
- 3963US12115158B2Survivin-targeting anti-tumor agents and uses thereofUNIV INDIANA RES & TECH CORP·Filed 2021·Granted Oct 15, 2024·0 cites·6 claims
- 4063US2023364243A1Cancer-selective target degradation by targeting group caged protacsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2023·Application pending·0 cites
- 4162US2023057177A1Modified proteins and protein degradersCULLGEN SHANGHAI INC·Filed 2021·Application pending·0 cites
- 4261US9682971B21,2,5-Substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 20, 2017·0 cites·13 claims
- 4360US10047101B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 14, 2018·0 cites·5 claims
- 4460US9440978B2Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1JANSSEN PHARMACEUTICA NV·Filed 2013·Granted Sep 13, 2016·0 cites·19 claims
- 4560US2025002505A1Synthesis of macroyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4660US2022054488A1Compositions and methods for treating cdk4/6-mediated cancerICAHN SCHOOL MED MOUNT SINAI·Filed 2021·Application pending·0 cites
- 4759US9695149B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 4, 2017·0 cites·20 claims
- 4858US2024335452A1Compositions and methods of combination therapy for targeting lymphomaCULLGEN SHANGHAI INC·Filed 2022·Application pending·0 cites
- 4958US2023183644A1Compositions of induced pluripotent stem cell-derived cells and methods of use thereofFUJIFILM CELLULAR DYNAMICS INC·Filed 2022·Application pending·0 cites
- 5058US2024034992A1Dopaminergic neurons comprising mutations and methods of use thereofFUJIFILM CELLULAR DYNAMICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 109 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jing Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →